Received: 3 August 2020
Accepted: 12 August 2020
First Online: 1 September 2020
Ethics approval and consent to participate
: The study was approved by the Local Ethical Committee: Comitato Etica per la Ricerca Clinica, Azienda Ospedale Università di Padova, Ref:4853/AO/20-AOP2012. Written informed consent was obtained from all patients.
: Written informed consent was obtained for all patients.
: PN received royalties from Intersurgical for Helmet Next invention and speaking fees from Philips, Resmed, MSD, and Novartis.The other authors have no competing interests to declare.The experimental software for EIT perfusion assessment was kindly provided by Drӓger Medical, Germany, without any financial supports.